Showing results (1-10 of 5) with videos related to
Sort By:
Pageof 1
Scandinavian Journal of Infectious Diseases|August 26, 2000
Hospital-treated infectious diseases in Western Pomeranian region in a 5-year surveillance: importance for travellersE Karpińska, A Leonciuk, M Wawrzynowicz-Syczewska, et al.Advances in Medical Sciences|December 2, 2011
Risk score based PEG Interferon alpha 2b and Ribavirin treatment response estimation model for genotype 1 chronic hepatitis C patientsK Jurczyk, L Laurans, E Karpińska, et al.Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|July 4, 2001
Parasitic cysts of the liver - practical approach to diagnosis and differentiationJ Niścigorska, T Sluzar, M Marczewska, et al.Journal of Viral Hepatitis|June 12, 2018
Durability of virologic response, risk of de novo hepatocellular carcinoma, liver function and stiffness 2 years after treatment with ombitasvir/paritaprevir/ritonavir±dasabuvir±ribavirin in the AMBER, real-world experience studyR Flisiak, E Janczewska, M Łucejko, et al.Alimentary Pharmacology & Therapeutics|September 10, 2016
Real-world effectiveness and safety of ombitasvir/paritaprevir/ritonavir ± dasabuvir ± ribavirin in hepatitis C: AMBER studyR Flisiak, E Janczewska, M Wawrzynowicz-Syczewska, et al.Pageof 1